Terazosin Hydrochloride Capsule
Product Images NDC 69292-201

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Terazosin Hydrochloride (NDC 69292-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amici Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

201-01 (69292 201 01)

This is a description of Terazosin capsules, each containing 100 capsules. Terazosin is used as an antihypertensive and relieves symptoms of benign prostatic hyperplasia. Each capsule contains an active ingredient that helps in controlling blood pressure and improving urine flow.*

FDA Label Image

201-10 (69292 201 10)

FDA Label Image

202-01 (69292 202 01)

FDA Label Image

202-10 (69292 202 10)

This text appears to be a product label for Terazosin Capsules, USP with NDC number 69292-202-10. It contains a warning to keep the medication out of reach of children.*

FDA Label Image

203-01 (69292 203 01)

FDA Label Image

203-10 (69292 203 10)

FDA Label Image

204-01 (69292 204 01)

FDA Label Image

204-10 (69292 204 10)

FDA Label Image

Terazosinhydrochloridechemicalstructure (Chemicalstructure)

FDA Label Image

Figure1 (Figure1)

FDA Label Image

Figure2 (Figure2)

FDA Label Image

Figure3 (Figure3)

This text provides data for the change from baseline in mL/sec for the months 0, 1, 2, and 3 (0, 1, 2, 3).*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.